Pfizer Inc. PFE on Wednesday shared topline results from the late-stage study of its cancer treatment, ELREXFIO (elranatamab) ...

As the entire globe anxiously waits for an end to the pandemic that has infected over 51 million people and taken over 1.2 million lives worldwide, Pfizer — the pharmaceutical company centered in New ...

RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...

Pfizer said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results. Earlier this year, Pfizer said ...

Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown efficacy in immunocompromised adults, the pharma announced Monday. In substudy B of Pfizer’s ongoing Phase 3 MONeT trial, Abrysvo ...

Leading vaccine makers Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) on Wednesday responded to President Donald Trump’s recent criticism that drug companies have yet to justify the success of their ...

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial. The ...

NEW YORK, June 24 /PRNewswire/ — Underscoring its commitment to scientific advancement, Pfizer Inc will launch Think Science Now, a science awareness program to promote exceptional researchers who ...

LONDON (Reuters) - U.S. drugmaker Pfizer Inc's effort to sweeten its bid for Britain's AstraZenaca Plc with commitments on research, manufacturing and jobs is claimed as a coup by the UK government, ...